Kiadis Pharma to Present at Upcoming Investor Conferences
May 16, 2018 02:00 ET
|
Kiadis Pharma Netherlands B.V.
Kiadis Pharma to Present at Upcoming Investor Conferences Amsterdam, The Netherlands, May 16, 2018 - Kiadis Pharma N.V. ("Kiadis Pharma" or the...
Kiadis Pharma N.V notice of Annual General Meeting of shareholders
April 23, 2018 01:00 ET
|
Kiadis Pharma Netherlands B.V.
Amsterdam, The Netherlands, April 23, 2017 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and Brussels: KDS), a...
Kiadis Pharma announces Annual Results for the year ended December 31, 2017
April 13, 2018 01:00 ET
|
Kiadis Pharma Netherlands B.V.
Kiadis Pharma announces Annual Results for the year ended December 31, 2017 Significantly strengthened cash position; raised over EUR 60 million in equity and debt (gross, including raise in...
Kiadis Pharma to announce Annual Results for the year ended December 31, 2017
March 29, 2018 01:00 ET
|
Kiadis Pharma Netherlands B.V.
Kiadis Pharma to announce Annual Results for the year ended December 31, 2017 Amsterdam, The Netherlands, March 29, 2018 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam...
Kiadis Pharma on track with European regulatory review for ATIR101
March 28, 2018 01:00 ET
|
Kiadis Pharma Netherlands B.V.
Kiadis Pharma on track with European regulatory review for ATIR101 Responses submitted to EMA Day 120 list of questions ...
Kiadis Pharma to Present at the Cowen and Company 38th Annual Health Care Conference
March 14, 2018 03:06 ET
|
Kiadis Pharma Netherlands B.V.
Kiadis Pharma to Present at the Cowen and Company 38th Annual Health Care Conference Amsterdam, The Netherlands, March 14, 2018 - Kiadis Pharma...
Kiadis Pharma N. V.: Kiadis Pharma raises €23.4 million in a private placement of 2.6 million new shares
March 13, 2018 02:00 ET
|
Kiadis Pharma Netherlands B.V.
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE,...
Kiadis Pharma N. V.: CORRECTION (Includes Disclaimers) Kiadis Pharma launches a private placement of approximately 2.6 million new shares
March 12, 2018 12:57 ET
|
Kiadis Pharma Netherlands B.V.
Not for release, publication or distribution, directly or indirectly, in or into the United States, Australia, Canada, Japan, south africa or Any other jurisdiction in which such release,...
Kiadis Pharma N. V.: Kiadis Pharma launches a private placement of approximately 2.6 million new shares
March 12, 2018 12:45 ET
|
Kiadis Pharma Netherlands B.V.
Kiadis Pharma launches a private placement of approximately 2.6 million new shares Amsterdam, The Netherlands, March 12, 2018 - Kiadis Pharma...
Kiadis to Host Key Opinion Leader Meeting on Addressing the Risks of Haploidentical HSCT in Blood Cancer
May 24, 2017 07:00 ET
|
Kiadis Pharma Netherlands B.V.
Kiadis to Host Key Opinion Leader Meeting on Addressing the Risks of Haploidentical HSCT in Blood Cancer ~ KOL meeting on 31 May in New York City with live webcast and Q&A session ~ ...